Table 3.
Multivariable Cox Proportional Hazard Models for Risk of Death or CVD per 1 Standard Deviation Increase in log10NGAL and Other Biomarkers
| Cardiovascular Mortality | All-Cause Mortality | Combined Cardiovascular Endpoint† | ||||
|---|---|---|---|---|---|---|
| HR (95% CI) | p | HR (95% CI) | p | HR (95% CI) | p | |
| # of Deaths/Events | 169 | 436 | 254 | |||
| Unadjusted | 1.72 (1.47–2.01)** | <0.001 | 1.48 (1.34–1.64)** | <0.001 | 1.48 (1.30–1.69)** | <0.001 |
| Model 1 | 1.34 (1.15–1.58)** | <0.001 | 1.22 (1.10–1.35)** | <0.001 | 1.29 (1.13–1.47)** | <0.001 |
| Model 2 | 1.33 (1.12–1.57)* | 0.001 | 1.19 (1.07–1.32)* | 0.001 | 1.26 (1.10–1.45)* | 0.001 |
| Model 3 | ||||||
| NGAL | 1.25 (1.05–1.48) | 0.01 | 1.14 (1.03–1.28) | 0.02 | 1.21 (1.05–1.39) | 0.01 |
| NT-proBNP | 1.80 (1.48–2.18)** | <0.001 | 1.42 (1.26–1.61)** | <0.001 | 1.52 (1.29–1.79)** | <0.001 |
| CRP | 1.09 (0.90–1.31) | 0.38 | 1.06 (0.95–1.19) | 0.29 | 1.08 (0.93–1.26) | 0.31 |
Model 1 - Adjusted for age and sex.
Model 2 - Adjusted for Model 1 + diabetes, hypertension, and current smoking (dichotomous variables) and systolic blood pressure, total cholesterol, HDL, creatinine clearance, and body mass index.
Model 3 - Adjusted for Model 2 + log10NT-proBNP and log10CRP.
Bold values are significant at p<0.05.
values are significant at p<0.01.
values are significant at p<0.001.
Combined Cardiovascular Endpoint = coronary revascularization, myocardial infarction, or CVD death.
CI = confidence interval; HR = hazard ratio.